Identification of Immune Responses to Japanese Encephalitis Virus Specific T Cell Epitopes
Open Access
- 12 February 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 8, 19
Abstract
Background: Due to the similarity between the dengue (DENV) and the Japanese encephalitis virus (JEV) there is potential for immune cross-reaction. We sought to identify T cell epitopes that are specific to JEV and do not cross react with DENV. Methodology: 20mer peptides were synthesized from regions which showed >90% conservation. Using IFNγ cultured ELISpot assays, we investigated JEV-specific T cell responses in DENV− and JEV− non-immune individuals (DENV−JEV− = 21), JEV seronegative and had not received the JE vaccine, but who were DENV seropositive (DENV+JEV− = 22), JEV+(seropositive for JEV and had received the JE vaccine), but seronegative for DENV (DENV−JEV+ = 23). We further assessed the responses to these peptides by undertaking ex vivo IFNγ assays and flow cytometry. Results: None of DENV−JEV− individuals responded to any of the 20 JEV-specific peptides. High frequency of responses was seen to 6/20 peptides by individuals who were JEV+ but DENV−, where over 75% of the individuals responded to at least one peptide. P34 was the most immunogenic peptide, recognized by 20/23 (86.9%) individuals who were DENV−JEV+, followed by peptide 3 and peptide 7 recognized by 19/23 (82.6%). Peptide 34 from the NS2a region, showed Ex vivo responses to these peptides were less frequent, with only 40% of individuals responding to peptide 34 and 16–28% to other peptides, probably as 5/6 peptides were recognized by CD4+ T cells. Discussion: We identified six highly conserved, T cell epitopes which are highly specific for JEV, in the Sri Lankan population. Since both JEV and DENV co-circulate in the same regions and since both JE and dengue vaccines are likely to be co-administered in the same geographical regions in future, these JEV-specific T cell epitopes would be useful to study JEV-specific T cell responses, in order to further understand how DENV and JEV-specific cellular immune responses influence each other.Keywords
Funding Information
- Centre for Dengue Research, University of Sri Jayewardenepura
- National Science Foundation
This publication has 44 references indexed in Scilit:
- Enumeration and Characterization of Human Memory T Cells by Enzyme-Linked Immunospot AssaysJournal of Immunology Research, 2013
- Suppression of Virus Specific Immune Responses by IL-10 in Acute Dengue InfectionPLOS Neglected Tropical Diseases, 2013
- Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8 + T cellsProceedings of the National Academy of Sciences, 2013
- Identification of serotype-specific T cell responses to highly conserved regions of the dengue virusesClinical and Experimental Immunology, 2012
- Preexisting Japanese Encephalitis Virus Neutralizing Antibodies and Increased Symptomatic Dengue Illness in a School-Based Cohort in ThailandPLOS Neglected Tropical Diseases, 2011
- Determinants of Inapparent and Symptomatic Dengue Infection in a Prospective Study of Primary School Children in Kamphaeng Phet, ThailandPLOS Neglected Tropical Diseases, 2011
- Allergies and Diabetes as Risk Factors for Dengue Hemorrhagic Fever: Results of a Case Control StudyPLOS Neglected Tropical Diseases, 2010
- The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal primingImmunology, 2009
- Viral Load, Clinical Disease Severity and Cellular Immune Responses in Primary Varicella Zoster Virus Infection in Sri LankaPLOS ONE, 2008
- High Pro-Inflammatory Cytokine Secretion and Loss of High Avidity Cross-Reactive Cytotoxic T-Cells during the Course of Secondary Dengue Virus InfectionPLOS ONE, 2007